NeuroOne holds annual meeting; elects directors Mathiesen and Andrle, ratifies auditor

NEUROONE MEDICAL TECHNOLOGIES Corp

Annual meeting held March 16, 2023; 9,719,474 shares (59.83%) represented.
Jeffrey Mathiesen re-elected as Class III director: 4,309,601 votes for, 268,402 withheld.
Edward Andrle re-elected as Class III director: 3,474,438 votes for, 1,103,565 withheld.
Baker Tilly U.S., LLP ratified as independent auditor for FY ending Sept 30, 2023: 9,661,674 for, 45,763 against, 12,037 abstain.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

NEUROONE MEDICAL TECHNOLOGIES Corp shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-03-16 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-03-16

Exact text from the filing

Proposal 2—Ratification of Appointment of Independent Registered Public Accounting Firm Votes For Votes Against Votes Abstain 9,661,674 45,763 12,037

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

NEUROONE MEDICAL TECHNOLOGIES Corp shareholders approved Election of Class III Directors at the 2023-03-16 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-03-16

Exact text from the filing

Proposal 1—Election of Directors Class III Nominees Votes For Votes Withheld Broker Non-Votes Jeffrey Mathiesen 4,309,601 268,402 5,141,471 Edward Andrle 3,474,438 1,103,565 5,141,471

View on SEC.gov

560 shareholder votes filed in the last 30 days. Browse all shareholder votes →

NEUROONE MEDICAL TECHNOLOGIES Corp filing history →

Source: SEC EDGAR

accession 0001213900-23-021037

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.